Louisville Lectures

AUGUST 6, 2021

After, Dr. Wade evaluates literature related to new therapies and indications for medications in patients with heart failure. Regan Wade presents "Heart Failure Pharmacology" by first reviewing heart failure pathophysiology as it relates to pharmacotherapy.

Internal Medicine 52

Internal Medicine Clinical Practice Education Clinic 52

Reflections of a Grady Doctor

APRIL 24, 2019

In 1992, I started at Meharry Medical College--the school that felt right but that I feared attending because, after Tuskegee University, it would be my second historically black college. This isn't so much about Alpha Omega Alpha Honor Medical Society. What happens to a dream deferred? Does it dry up like a raisin in the sun?

Medical Student 52

Medical Student Internal Medicine Medical IT 52

Physician's Weekly

JUNE 25, 2025

It’s “going to streamline it in some incremental ways only,” Dr. Adam Gaffney , a critical care doctor and assistant professor at Harvard Medical School, told NBC News. Medical professionals will be required to review all denials (though insurers say they already do this). But experts say the changes may not go far enough.

Insurance 52

Insurance Patient-Centered Electronics Physicals 52

Physician's Weekly

JUNE 19, 2025

Patients with mental health and/or SUDs disproportionately seek medical care in EDs, yet research rarely examines first-hand accounts of their experiences,” wrote study corresponding author Linda M. Embedding a psychiatric registered nurse or SUD counselor can decompress boarding and free physicians to manage medical presentations.

Mental Health 52

Mental Health Physicals Patient-Centered Patients 52

FDA Law Blog

JANUARY 18, 2022

Cato — On December 10, 2021, FDA issued a discussion paper titled 3D Printing Medical Devices at the Point of Care seeking feedback on FDA regulatory oversight of various 3D-printing scenarios, in order to inform future policy development. products intended for medical purposes). products intended for medical purposes).

Medical 98

Medical Manufacturing Healthcare Government 98

Dr. Wes

SEPTEMBER 12, 2020

Since December 2018, a rash of antitrust lawsuits have been filed against the American Board of Medical Specialties (ABMS) and their member boards.

Medical Specialty 100

Medical Specialty Medical IT 100

FDA Law Blog

MARCH 6, 2023

By Véronique Li, Senior Medical Device Regulation Expert — A year ago, we blogged about a proposed rule that would replace the Quality System Regulation (QSR) at 21 C.F.R. The proposed rule was published on February 23, 2022 and was first heralded by FDA in 2018 and introduced in the Spring 2018 regulatory agenda.

Manufacturing 105

Manufacturing Management Medical Provider 105

The Clinical Problem Solvers

SEPTEMBER 28, 2019

Dr.’s Vivek Murthy, Bridget O’Brien, and Gurpreet Dhaliwal sought to answer this question in a 2018 study. This is a peer-nominated group of academic clinicians renowned for their medical knowledge, teaching & communication skills, professionalism, and high-quality patient care. “How do they do it?!!”

Lab Testing 52

Lab Testing Clinic Education Clinical Practice 52

FDA Law Blog

JANUARY 18, 2022

Cato — On December 10, 2021, FDA issued a discussion paper titled 3D Printing Medical Devices at the Point of Care seeking feedback on FDA regulatory oversight of various 3D-printing scenarios, in order to inform future policy development. products intended for medical purposes). products intended for medical purposes).

Medical 75

Medical Manufacturing Healthcare Government 75

PEMBlog

OCTOBER 31, 2024

However, this large study shows that probiotics do not significantly shorten illness duration, improve symptoms, or reduce the need for additional medical visits. 2018 Nov 22;379(21):2002-2014. N Engl J Med 2018; 379:2015-2026. By using the latest research, parents can focus on more effective treatments like hydration.

Hospital 105

Hospital Illness Patients Provider 105

My Green Doctor

APRIL 4, 2025

New Research: Teaching Patients about Climate Resilience Newly published original research co-authored by My Green Doctor’s Dr. Todd Sack concludes that, “ the medical office waiting room appears to be an accepted, time-efficient, and effective site to communicate knowledge on climate change and health. ” Contact us today!

Healthcare Professional 52

Healthcare Professional Healthcare Community Medical Advice 52

Aspiring Minority Doctor

MARCH 14, 2022

For those who aren’t aware, today is Match Day where thousands of 4th year medical students and graduates find out if they have secured a residency position. For many, this is a joyous day filled with celebrations and sighs of relief, but for the unmatched, this can be one of the most depressing experiences of an entire medical school career.

Medical Student 52

Medical Student Medical Management IT 52

The Clinical Problem Solvers

JANUARY 18, 2021

Harvard Medical School Primary Care Blog. Creating a segregated medical profession: African American physicians and organized medicine, 1846-1910. 1:05:57 Outtakes Takeaways Name Racism for What It Is If we don’t explicitly say the word racism, and identify its historical context, then we are complicit in its denial.

Community 52

Community Medical Individual IT 52

FDA Law Blog

MAY 13, 2024

Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). RWE is “the clinical evidence regarding the usage, and potential benefits or risks, of a medical product derived from analysis of RWD.” By Jeffrey N.

Medical 111

Medical Clinic Patients IT 111

FDA Law Blog

JULY 17, 2024

An Opportunity to Leverage the Newly Created Rare Disease Advisory Committee across CDER and CBER In Frank and James’ 2018 proposal there was also a recommendation for the formation of a Rare Disease Advisory Committee, which would allow FDA access to experts in the science of small trials and other aspects of rare disease research.

Patient-Centered 105

Patient-Centered Community Medical Specialty Clinic 105

The Clinical Problem Solvers

OCTOBER 18, 2022

Correctional officers act as gatekeepers, deciding who does and does not need medical care. This means that people who are incarcerated are often not believed when they say they need medical care.

Healthcare Professional 52

Healthcare Professional Healthcare Patient-Centered Mental Health 52

Physician's Weekly

JUNE 25, 2025

Supporters said it was meant to close a legal loophole created in 2018 when a federal law allowed states to regulate hemp, a plant that can be processed to create THC. Recreational use is banned, and the medical marijuana program is limited. The proposed law would have made it a misdemeanor to own, make or sell THC products.

Medical 52

Medical IT Family Practice Internal Medicine 52

FDA Law Blog

OCTOBER 4, 2022

By Véronique Li, Senior Medical Device Regulation Expert — Allegations of regulatory misconduct are claims that a medical device manufacturer or marketers of medical devices operate in such a way that violates the law. The time in which these requests were completed ranged from months to years. This is unproductive.

Manufacturing 52

Manufacturing Medical Provider IT 52

FDA Law Blog

JULY 7, 2021

Gibbs — In the first challenge ever brought against FDA’s rarely used power to ban a medical device, a court found FDA overstepped its authority and overturned the ban. In 2018, a Massachusetts court upheld the use of GEDs in treating patients with SIB/AB, finding the device to be effective in treating refractory patients.

Medical 52

Medical Patient-Centered Patients IT 52

FDA Law Blog

AUGUST 4, 2022

In September 2020, the Agency issued an unfavorable advisory opinion to Pfizer, concluding that the proposal was “highly suspect” under the AKS “because one purpose of the [proposed program]—perhaps the primary purpose—would be to induce Medicare beneficiaries to purchase [Pfizer’s] federally reimbursable Medications.” Pfizer, Inc.

Manufacturing 98

Manufacturing Medical Government IT 98

FDA Law Blog

NOVEMBER 20, 2024

Chemical characterization identifies and quantifies chemicals that may be released from the medical device, while a toxicological risk analysis (TRA) evaluates the risks to the patient associated with the chemicals identified. Data from chemical characterization studies must be evaluated in a separate TRA following ISO 10993-17 guidelines.

Provider 59

Provider Medical Manufacturing Consulting 59

FDA Law Blog

DECEMBER 2, 2024

We noted that the draft guidance’s discussion on determining a device’s contact duration raised concern as it contradicted ISO 10993-1:2018, Biological evaluation of medical devices —Part 1: Evaluation and testing within a risk management process. the new draft guidance and ISO 10993-1: 2018) leads to more uncertainty for sponsors.

Consulting 52

Consulting Medical Management Specialization 52

Medical Xpress

MARCH 9, 2023

When Dana Avellino, now 36, first noticed a lump near her groin in the summer of 2018, she thought it was related her recent cesarean section. Her younger daughter was only 2 months old at the time.

IT 75

IT Medical 75

FDA Law Blog

OCTOBER 30, 2022

This draft guidance proposes updates to FDA’s Breakthrough Devices Program, which is outlined in a separate December 2018 guidance document. FDA intends to incorporate these updates into the December 2018 Breakthrough Devices Program guidance after considering public comment.

Diagnosis 59

Diagnosis Clinic Provider IT 59

Medical Xpress

DECEMBER 20, 2022

Switching the painkiller codeine to a prescription-only medicine in 2018 led to a 37 percent overall drop in its consumption across Australia, according to new findings from wastewater sampling published in the journal Addiction.

IT 70

IT 70

Medical Xpress

FEBRUARY 9, 2023

federal legislation—the Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill—has ushered in an explosion of interest in the medical potential of cannabis-derived cannabidiol, or CBD. Over the last five years, an often forgotten piece of U.S.

IT 40

IT Medical 40

FDA Law Blog

JULY 25, 2023

The canary in the coal mine for nitrosamines was their 2018 appearance in blood pressure medications called sartans. According to several studies, nitrosamines are a potentially potent carcinogen, depending on the length and depth of exposure. What is FDA doing about NDRSIs? In addition to the FDA’s efforts, agencies in the E.U.,

IT 52

IT Manufacturing Individual Medical 52

FDA Law Blog

AUGUST 2, 2022

As a reminder, cannabis remains a schedule I substance under the federal Controlled Substances Act (“CSA”), which by definition means it does not have an accepted medical use in treatment in the United States and thus cannot be legally sold or marketed for any purpose. 21 U.S.C. § 812(b)(1). 26, 2022). CRCC Letter, 3.

Medical 96

Medical Individual Provider Community 96

The Clinical Problem Solvers

DECEMBER 16, 2020

Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice.

Clinic 52

Clinic Education Clinical Practice Patient-Centered 52

FDA Law Blog

OCTOBER 5, 2022

For additional information on the structure and referenced guidance documents, please refer to Table 1 of the Electronic Submission Template for Medical Device 510(k) Submissions guidance document.) eSTAR will be mandatory October 1, 2023 for all 510(k) submissions and subsequent supplements and amendments (e.g. add-to-files). add-to-files).

Electronics 45

Electronics Medical Screening IT 45

FDA Law Blog

FEBRUARY 28, 2022

Bauer, Senior Regulatory Drug Expert — Our readers probably know that we value and advocate for patient engagement as an essential component in the development of medical products (see our firm’s commitment here ). Valentine & Larry J.

Patients 52

Patients Clinic Medical Patient-Centered 52

FDA Law Blog

FEBRUARY 18, 2025

The answers below are based on my experience as a reviewer and compliance officer at FDA during the 5-week 2018/2019 government shutdown. During the 5-week shutdown in 2018/2019, PDUFA funding was the most robust and could have funded several months of review operations. What does it mean for FDA staff?

Government 76

Government Management IT Medical 76

Aspiring Minority Doctor

APRIL 17, 2021

When I first applied in the 2018 cycle, the total I spent was $1910 ($1686 in the actual match and the rest during SOAP.reviewing my payment history now). I originally planned to write weekly, but life remained busy as usual, so I only wrote two posts, one from 10/22/2020 and another from 10/23/2020. Anyway, back to ERAS. Let that sink in.

Medical Student 52

Medical Student IT Telemedicine Medical 52

FDA Law Blog

AUGUST 12, 2021

Koblitz — About two weeks ago, FDA made an exciting announcement (and it remains exciting even if we’re late posting about it): FDA approved the first interchangeable biosimilar. On July 30, 2021, FDA approved Semglee (insulin glargine-yfgn), an insulin product that relies on Lantus (insulin glargine) as its reference product.

Clinic 98

Clinic Provider IT Patients 98

PEMBlog

APRIL 22, 2025

Discuss options like oral medications, intranasal routes, or the presence of trusted caregivers during procedures. What you can do: Partner with outpatient providers to ensure follow-up is arranged for behavioral, medical, or developmental concerns. Medical Management of Children With Autism in the Emergency Department.

Families 80

Families Family Patient-Centered Physicals 80

Aspiring Minority Doctor

DECEMBER 8, 2021

ProCompression Socks Throwback pic from one of my 2018-2019 24hr call shifts I swear by Pro Compression socks! I bought a few of these socks (and was also gifted some by my little brother) when I was a medical student, and to this day I still wear the same socks with great compression. Happy December!

Electronics 52

Electronics Healthcare Professional IT Medical Student 52

GeriPal

MAY 19, 2022

Summary Transcript Summary. A patient is on morphine and you want to convert it to another opioid like hydromorphone (dilaudid). How do you do that? Do you do what I do, pull out a handy-dandy opioid equianalgesic table to give you a guide on how much to convert to? . which advocates for an updated, wait for it… equianalgesic table! . Drew: Yeah.

IT 139

IT Patients Individual Relationship 139